Truist Securities Downgrades Aerie Pharmaceuticals to Hold

Truist Securities analyst Gregory Fraser downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Hold.

Truist Securities analyst Gregory Fraser downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Hold.

Total
0
Shares
Related Posts
Read More

Larry Summers Says US Facing Complex Challenges: ‘Curbing Inflation Comes First, But We Can’t Stop There’

Former Treasury Secretary Lawrence H. Summers believes the United States is facing a very complex set of macroeconomic challenges but said the current situation does not include low unemployment and is not as grave as the 2009 financial crisis or inflation during the 1970s.

QQQM